Ventilation Strategy Reduces Postoperative Atelectasis

Status Withdrawn

Clinical Trial Summary

Atelectasis is common during and after general anesthesia. The investigators hypothesized that a ventilation strategy with a combination of 1) continuous positive airway pressure (CPAP) or positive end-expiratory pressure (PEEP) and 2) a reduced end-expiratory oxygen fraction (FETO2) before commencing mask ventilation with CPAP after extubation would reduce the area of postoperative atelectasis.

Clinical Trial Description

During general anesthesia, the combination of reduced functional residual capacity (FRC), high inspiratory oxygen fraction (FIO2), and airway closure are the main factors implicated in the atelectasis, shunt and shunt-like effects that account for the majority of the impaired oxygenation seen during general anesthesia.

Previous studies have shown that formation of atelectasis during preoxygenation and induction of anesthesia can be avoided by adding a continuous positive airway pressure (CPAP) followed by a positive end-expiratory pressure (PEEP).During emergence from anesthesia, high concentrations of oxygen predispose to atelectasis formation. Even a recruitment maneuver, followed by ventilation with 100% oxygen with a PEEP/CPAP of 10 cm H2O until extubation, failed to improve postoperative oxygenation compared with that achieved with zero end-expiratory pressure (ZEEP).This failure may have been caused by the presence of lung regions with high oxygen concentrations.

The investigators hypothesized that by inducing and discontinuing anesthesia during CPAP/PEEP and deliberately reducing FIO2 after extubation, postoperative atelectasis would be reduced compared with standard protocols. To test our hypothesis, the investigators studied 1) a control group with no CPAP/PEEP and a FIO2 of 1.0 while breathing spontaneously after extubation, and 2) an intervention group that was on CPAP/PEEP of 6 cmH2O from induction to extubation and that received an FIO2 of 1.0 until extubation and then an FIO2 of 0.3 via a facemask while on CPAP after extubation. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Pulmonary Atelectasis

Clinical Trial Details

NCT number	NCT01911923
Study type	Interventional
Source	Landstinget Västmanland
Contact
Status	Withdrawn
Phase	N/A
Start date	August 2013
Completion date	November 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02870842` - Fraction of Inspired Oxygen and Atelectasis in Children	N/A
Withdrawn	`NCT02952066` - Expressions of TRPV1 in Airway of Asthmatics	N/A
Recruiting	`NCT03311347` - Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria	N/A
Completed	`NCT04116567` - Lung Ultrasonography After Laparoscopic Gynecologic Surgery
Completed	`NCT02584023` - Lung Ultrasound and Alveolar Recruitment in Mechanically Ventilated Infants	N/A
Recruiting	`NCT06205212` - High-flow Nasal Oxygenation During Preoxygenation and Atelectasis	N/A
Completed	`NCT04566419` - poStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis Incidence	N/A
Completed	`NCT04993001` - Impact of an Open Lung Extubation Strategy on Postoperative Pulmonary Complications	N/A
Completed	`NCT03630484` - Ventilator Hyperinflation and Manual Rib Cage Compression	N/A
Completed	`NCT02262182` - Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® After Cardiac Surgery in the Management of Postoperative Atelectasis	N/A
Completed	`NCT01476254` - Respiratory Complications After Laparoscopic Surgery	N/A
Withdrawn	`NCT04566172` - Preoperative Optimization to Improve Functional Status	N/A
Completed	`NCT03763461` - HFNC During Awake Craniotomy - Impact on Patient Comfort	N/A
Recruiting	`NCT06430229` - Atelectasis Frequency in Different Ventilation Modes	N/A
Recruiting	`NCT06181279` - Effects of Individualized PEEP Guided by Driving Pressure on Postoperative Atelectasis in Patients With Morbid Obesity	N/A
Enrolling by invitation	`NCT05434624` - QT Distance and P Dispersion in ECG in Patients Having Bronchoscopy in the ICU	N/A
Withdrawn	`NCT02070445` - Ventilation During Cardiopulmonary Bypass (CPB) for Cardiac Surgery
Recruiting	`NCT02431455` - The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery	N/A
Completed	`NCT03686631` - The Digital Incentive Spirometer (DIS): Improving Adherence to Incentive Spirometry	N/A
Active, not recruiting	`NCT03009331` - Descriptive and Comparative Study of Respiratory Function in the Postoperative Cardiac Surgery Patient	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.